Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences POC Diagnostics, Global Health-Viral Diseases 2017

Gene Dantsker's Biography

Gene Dantsker, Director, Business Development and Licensing, Qualcomm LIFE, Inc.

Gene Dantsker is Director of Business Development for Qualcomm Life. Prior to this role, Dr. Dantsker worked across the spectrum of therapy and diagnostic technology solutions. He was co-founder and VP of Technology of Nanostream, Inc. a biotech company and provider of high-throughput bio-analytical instruments to pharmaceutical companies. Subsequently Gene was CTO of Adnavance Technologies, a provider of ultra-sensitive medical diagnostic products. Gene also served on the Board of Directors of D-Wave Systems, a pioneer in quantum computing, with leading Silicon Valley VCs, as well as heavily consulted the company in business development, IP strategy and operational infrastructure. He holds B.S. degrees in Physics and Mathematics from the University of Maryland, a Ph.D. in Physics from the University of California at Berkeley, and an MBA from San Diego State University, where he was class valedictorian. He has over 20 patents.

Gene Dantsker Image

Internet of Medical Things for Intelligent Care

Wednesday, 4 October 2017 at 13:30

Add to Calendar ▼2017-10-04 13:30:002017-10-04 14:30:00Europe/LondonInternet of Medical Things for Intelligent CarePOC Diagnostics, Global Health-Viral Diseases 2017 in Coronado Island, CaliforniaCoronado Island,

Modern health care is undergoing an unprecedented shift from volume-driven to value-driven medicine, characterized by outcomes-based payment models and enabled by disruptive technologies that are decentralizing health care and engaging the patient. Access to the patient is enabled both via the evolving pervasive communication infrastructure as well as a plethora of widespread communication-enabled medical devices called the Internet of Medical Things (IOMT). As a result, the point of care is shifting and now spans the entire acuity spectrum, from hospital to home and points in between. Offerings in therapeutics and diagnostics are shifting toward those that incorporate compliance and outcomes via real world data captured from the patients’ interaction with digitally-enabled drug delivery systems as well as companion diagnostics, resulting in value models for providers, manufacturers and payers to enact actionable visibility into patient populations that are lowering costs and improving targeted delivery of healthcare.

Add to Calendar ▼2017-10-02 00:00:002017-10-04 00:00:00Europe/LondonPOC Diagnostics, Global Health-Viral Diseases 2017POC Diagnostics, Global Health-Viral Diseases 2017 in Coronado Island, CaliforniaCoronado Island,